Digital application for drug product potency target evaluation in biopharmaceutical manufacturing

被引:1
|
作者
Shen, Darrick [1 ]
Panjwani, Shyam [1 ]
Spetsieris, Konstantinos [1 ]
机构
[1] Bayer Pharmaceut, 800 Dwight Way, Berkeley, CA 94710 USA
关键词
biologics manufacturing process; Monte Carlo simulation; out-of-specification (OOS) risk; potency; software application development; statistical modeling; sterile fill finish;
D O I
10.1002/btpr.3461
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Biopharmaceutical manufacturing entails a series of highly regulated steps. The manufacturing of safe and efficacious drug product (DP) requires testing of critical quality attributes (CQAs) against specification limits. DP potency concentration, which measures the dosage strength of a particular DP, is a CQA of great interest. In order to minimize the DP potency out-of-specification (OOS) risk, sterile fill finish (SFF) process adjustments may be needed. Varying the potency targets can be one such process adjustment. To facilitate such evaluation, data acquisition and statistical calculations are required. Regularly conducting the OOS risk assessment manually using commercial statistical software can be tedious, error-prone, and impractical, especially when several alternate potency targets are under consideration. In this work, the development of a novel framework for OOS risk assessment and deployment of cloud-based statistical software application to facilitate the risk assessment are presented. This application is intended to streamline the assessment of alternate potency targets for DP in biologics manufacturing. The major aspects of this potency targeting application development are presented in detail. Specifically, data sources, pipeline, application architecture, back-end and front-end development as well as application verification are discussed. Finally, several use cases are presented to highlight the application's utility in biologics manufacturing.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] The impact of endotoxin masking on the removal of endotoxin during manufacturing of a biopharmaceutical drug product
    Wespel, Martina
    Geiss, Melanie
    Nagele, Matthias
    Combe, Stephanie
    Reich, Johannes
    Studts, Joey
    Stolzenberger, Jessica
    JOURNAL OF CHROMATOGRAPHY A, 2022, 1671
  • [2] Particle Shedding from Peristaltic Pump Tubing in Biopharmaceutical Drug Product Manufacturing
    Saller, Verena
    Matilainen, Julia
    Grauschopf, Ulla
    Bechtold-Peters, Karoline
    Mahler, Hanns-Christian
    Friess, Wolfgang
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 104 (04) : 1440 - 1450
  • [3] Data mining algorithm for pre-processing biopharmaceutical drug product manufacturing records
    Casola, Gioele
    Siegmund, Christian
    Mattern, Markus
    Sugiyama, Hirokazu
    COMPUTERS & CHEMICAL ENGINEERING, 2019, 124 : 253 - 269
  • [4] Uncertainty-conscious methodology for process performance assessment in biopharmaceutical drug product manufacturing
    Casola, Gioele
    Sugiyama, Hirokazu
    Siegmund, Christian
    Mattern, Markus
    AICHE JOURNAL, 2018, 64 (04) : 1272 - 1284
  • [5] Digital Twins and AI Reshape Biopharmaceutical Manufacturing
    Macdonald G.J.
    Genetic Engineering and Biotechnology News, 2022, 42 (08): : 44 - 46
  • [6] Data-driven anomaly detection and diagnostics for changeover processes in biopharmaceutical drug product manufacturing
    Zeberli, Anicia
    Badr, Sara
    Siegmund, Christian
    Mattern, Markus
    Sugiyama, Hirokazu
    CHEMICAL ENGINEERING RESEARCH & DESIGN, 2021, 167 : 53 - 62
  • [7] Multi-stage and multi-objective decision-support tool for biopharmaceutical drug product manufacturing: Equipment technology evaluation
    Zurcher, Philipp
    Shirahata, Haruku
    Badr, Sara
    Sugiyama, Hirokazu
    CHEMICAL ENGINEERING RESEARCH & DESIGN, 2020, 161 : 240 - 252
  • [8] High-potency drug manufacturing
    Anon
    Chemical and Engineering News, 2001, 79 (14):
  • [9] Application of Overall Equipment Effectiveness to Biopharmaceutical Manufacturing
    Junker, Beth H.
    BIOPHARM INTERNATIONAL, 2009, 22 (05) : 40 - +
  • [10] Digital Twins in Pharmaceutical and Biopharmaceutical Manufacturing: A Literature Review
    Chen, Yingjie
    Yang, Ou
    Sampat, Chaitanya
    Bhalode, Pooja
    Ramachandran, Rohit
    Ierapetritou, Marianthi
    PROCESSES, 2020, 8 (09)